Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Vaccines and monoclonal antibodies being developed for respiratory syncytial virus

Hybrid immunity retained six months after SARS-CoV-2 exposure

Hybrid immunity retained six months after SARS-CoV-2 exposure

Gene therapy approach delays disease onset in humanized mouse models of familial ALS

Gene therapy approach delays disease onset in humanized mouse models of familial ALS

Moderna COVID vaccine is more effective in older and sicker veterans over time

Moderna COVID vaccine is more effective in older and sicker veterans over time

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

Why Omicron is more infectious than other SARS-CoV-2 variants

Why Omicron is more infectious than other SARS-CoV-2 variants

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

SARS-CoV-2 spike protein can lead to heart muscle injury through the inflammatory process

The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines

The durability of immunity and the likelihood of breakthrough infections following vaccination with four well-studied COVID-19 vaccines

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Gut-lung axis: Using commensal bacteria to reinforce mucosal immunity

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

Healthy, cancer, and immunosuppressed patients all benefit from COVID boosters

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

Model predicts effectiveness of COVID-19 vaccines against circulating SARS-CoV-2 variants

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Gene therapy for degenerative retinal disease has no safety concerns but fails to improve vision loss

Gene therapy for degenerative retinal disease has no safety concerns but fails to improve vision loss

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

Study analyzes how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2

Direct comparison of immune memory responses to four COVID-19 vaccines

Direct comparison of immune memory responses to four COVID-19 vaccines

New therapeutic approach harnesses the body's immune system to protect against brain damage

New therapeutic approach harnesses the body's immune system to protect against brain damage

Study investigates COVID-19 vaccination in pregnancy

Study investigates COVID-19 vaccination in pregnancy

Mice live longer with nasal gene therapy

Mice live longer with nasal gene therapy

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies